AstraZeneca's vaccine Fluenz gets Europe-wide approval
This article was originally published in Scrip
Executive Summary
AstraZeneca's nasally administered influenza vaccine, Fluenz, should be available in selected European territories for the 2012-13 'flu season after receiving approval for marketing across the EU and the European Economic Area.